Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0019204 (
hepatocellular carcinoma
)
71,386
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) is a component of the replication complex associated with various cellular proteins. It has been reported that
G protein pathway suppressor 2
(
GPS2
) is a potential NS5A-binding factor, as identified in a yeast two-hybrid screens of human cDNA library using viral proteins as baits [1]. In this study, we demonstrated the interaction between
GPS2
and NS5A in mammalian cells by coimmunoprecipitation analysis and found that both exogenously and endogenously expressed
GPS2
interacted with NS5A of genotype 1b and 2a. Mutagenesis study demonstrated that Domain I of NS5A and coiled-coil domain of
GPS2
are responsible for the interaction. Knockdown of
GPS2
in
hepatoma
cell lines suppressed the replication of HCV RNA, which can be rescued by the expression of an RNAi-resistant
GPS2
. Furthermore, overexpression of
GPS2
enhanced the association of NS5A with a proviral cellular factor, human vesicle-associated membrane protein-associated protein A (VAP-A), while knockdown of
GPS2
disrupted interaction between VAP-A and NS5A. Taken together, our results suggest that
GPS2
acts as a bridge between NS5A and VAP-A and is required for efficient HCV replication.
...
PMID:GPS2 is required for the association of NS5A with VAP-A and hepatitis C virus replication. 2422 74